Schedules for Gemcitabine, Nab-Paclitaxel for Pancreatic Cancer
2 意见
administrator
07/30/23
A panel of experts in gastrointestinal oncology discusses schedules for gemcitabine and nab-paclitaxel in metastatic pancreatic cancer, including alternating with FOLFIRINOX.
显示更多
脸书评论
没有找到评论